Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
While routine liver function testing is not standard for all patients on semaglutide, those with known hepatic disease may benefit from periodic assessment of ALT, AST, alkaline phosphatase, and bilirubin levels
November 25 Product: Shorla Oncologys Imkeldi Indication: Several forms of leukemia and other cancers The FDA on Monday signed off on Shorla Oncologys Imkeldi, an oral solution indicated for the treatment of certain types of chronic myeloid leukemia and acute lymphoblastic leukemia, as well as other cancers such as myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis and dermatofibrosarcoma protuberans
In a letter (PDF) submitted on August 28, the drug makers argued that including general causation in the first phase of discovery will further streamline the litigation, since issues will overlap substantially with information that will need to be exchanged regarding the preemption issues about the adequacy of the warning labels
.png)
Injectable research peptides, like BPC-157 and TB-500, exploded in popularity last year, going from niche biohacker protocol to mainstream curiosity
